Trump reclassifies cannabis to Schedule III, easing restrictions on marijuana
US President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, DC,…
health care industry
Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…
Anti-obesity pills from Novo Nordisk and Eli Lilly arrive
Daniel Grill tetra images | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Trump confirms possible drug reclassification, but stocks fall
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
FDA May Add Stricter Safety Warning to Covid Shots
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Food brands chase Fibermaxxing trend with new fiber-rich products
Workers hang on a Pepsi sign on a building outside Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, USA,…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
A biotech stock for investors who fear investing in the risky industry
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…